Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 9,187

Assumptions: The Case Against Reality

When it comes to scientific theory, (or your personal life) be sure to question everything.

- The theories we build to navigate the world, both scientifically and in our personal lives, all contain assumptions. They’re a critical part of scientific theory.

- Cognitive psychologist Donald Hoffman urges us to always question those assumptions. In this way, by challenging ourselves, we come to a deeper understanding of the task at hand.

- Historically, humans have come to some of our greatest discoveries by simply questioning assumed information.

Continue reading “Why should you always assume you’re wrong? Science” | >

United Parcel Service Inc. is striking a series of drone-delivery agreements with health-care groups as it develops new technology pitched to the growing medical market.

The plans include expanding the use of drones to deliver cargo such as medical samples and supplies on hospital campuses in Utah and elsewhere, and an agreement with CVS Health Corp. to evaluate the use of drones for home delivery of prescriptions and other products, UPS said Monday.

The agreements are the first UPS has announced since the package delivery giant won U.S. regulatory approval to operate commercial drone flights through the company’s Flight Forward subsidiary. The nod from the Federal Aviation Administration paves the way for UPS to scale up operations as it competes with FedEx Corp., Amazon.com Inc. and others vying to develop drone delivery services in the U.S.

Read more | >

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

James Peyer of Kronos BioVentures gave a talk about the investment aspects of rejuvenation biotechnology, first explaining the effects of the population pyramid, showing the audience why cures for age-related diseases are such a necessity, and comparing population projections. He explained the startup ecosystem in biotechnology, drug approval, and IPO prices for nascent biotechnology companies. Finally, he explained the financial issues facing startup biotechnology companies and his company’s role in helping these companies achieve their goals.

[/p].

Read more | >